Abstract: Provided herein are compounds used to inhibit the deamination enzyme responsible for the inactivation of therapeutic compounds, and methods of using them.
Type:
Grant
Filed:
April 6, 2010
Date of Patent:
December 11, 2012
Assignee:
Eisai Inc.
Inventors:
Sergei Belyakov, Bridget Duvall, Dana Ferraris, Gregory Hamilton, Mark Vaal